Loading...
Docoh

Bruce Fund

Filed: 13 Aug 19, 9:15am


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT

INVESTMENT COMPANY

 

Investment Company Act File number: 811-01528

 

Bruce Fund, Inc.

(Exact name of registrant as specified in charter)

 


20 North Wacker Drive, Suite 2414, Chicago, IL 60606

(Address of principal executive offices) (Zip code)

 


Robert B. Bruce

20 North Wacker Drive, Suite 2414

Chicago, Illinois 60606

(Name and address of agent for service)

 

Registrant's telephone number, including area code: 312-236-9160

 

Date of fiscal year end: June 30

 

Date of reporting period:07/01/2018 - 06/30/2019

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (Secs. 239.24 and 274.5 of this chapter),to file reports with the Commission, not later than August 31 of each year, containing the registrant's proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b 1-4).The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget C'OMB") control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. Sec. 3507.

 


 

 

 

Bruce Fund        
Proxy Voting Record 7/1/2018 - 6/30/2019      
         

Security

Name

TickerCusip

Meeting

Date

Proposed

(M) or (S)

DescriptionVote

For,

Against

or Abstain

For or Against

Management

         
EDAPEDAP2683111076/28/2019MAuditorsYFF
EDAPEDAP2683111076/28/2019MFinancialsYFF
EDAPEDAP2683111076/28/2019MAllocation net lossYFF
EDAPEDAP2683111076/28/2019MDirectorsYFF
EDAPEDAP2683111076/28/2019MShare issuanceNAF
         
AbbvieABBV00287Y1095/3/2019MDirectorsYFF
AbbvieABBV00287Y1095/3/2019MAuditorsYFF
AbbvieABBV00287Y1095/3/2019MSay on PayYFF
AbbvieABBV00287Y1095/3/2019MCertificate amendmentYFF
AbbvieABBV00287Y1095/3/2019SLobbyingYFA
AbbvieABBV00287Y1095/3/2019Sdrug pricingNAA
AbbvieABBV00287Y1095/3/2019SIndependent ChairmanNAA
         
AppleAPPL0378331003/1/2019MDirectorsYFF
AppleAPPL0378331003/1/2019MAccountingYFF
AppleAPPL0378331003/1/2019MExecutive CompensationYFF
AppleAPPL0378331003/1/2019Sproxy accessNAA
AppleAPPL0378331003/1/2019SdiversityNAA
         
GoldcorpGG3809564094/4/2019MNewmont arrangmentYFF
         
XtantXTNT98420P3088/1/2018MDirectorsYFF
XtantXTNT98420P3088/1/2018MAccountingYFF
XtantXTNT98420P3088/1/2018MIncentive planYFF
         
Compass MineralsCMP20451N1015/9/2019MDirectorsYFF
Compass MineralsCMP20451N1015/9/2019MAccountingYFF
Compass MineralsCMP20451N1015/9/2019MExecutive CompensationYFF
         
BungeBGG169621055/23/2019MDirectorsYFF
BungeBGG169621055/23/2019MAccountingYFF
BungeBGG169621055/23/2019MExecutive CompensationYFF
         
InsteelIIIN45774W1082/12/2019MDirectorsYFF
InsteelIIIN45774W1082/12/2019MAccountingYFF
InsteelIIIN45774W1082/12/2019MExecutive CompensationYFF
         
MerckMRK58933Y1055/28/2019MDirectorsYFF
MerckMRK58933Y1055/28/2019MAccountingYFF
MerckMRK58933Y1055/28/2019MIncentive stockYFF
MerckMRK58933Y1055/28/2019MCompensationYFF
MerckMRK58933Y1055/28/2019SIndependent ChairmanNAA
MerckMRK58933Y1055/28/2019SStock buybacks/executive incentivesNAA
MerckMRK58933Y1055/28/2019Sdrug pricingNAA
         
IBMIBM4592001014/30/2019MDirectorsYFF
IBMIBM4592001014/30/2019MAccountingYFF
IBMIBM4592001014/30/2019MExecutive CompensationYFF
IBMIBM4592001014/30/2019MIncentive performanceYFF
IBMIBM4592001014/30/2019SWritten consentNAA
IBMIBM4592001014/30/2019SIndependent ChairmanNAA
         
PfizerPFE7170811034/25/2019MDirectorsYFF
PfizerPFE7170811034/25/2019MAccountingYFF
PfizerPFE7170811034/25/2019MExecutive CompensationYFF
PfizerPFE7170811034/25/2019M Stock PlanYFF
PfizerPFE7170811034/25/2019SWritten ConsentNAA
PfizerPFE7170811034/25/2019SLobbyingYFA
PfizerPFE7170811034/25/2019SIndependent ChairNAA
PfizerPFE7170811034/25/2019SDrug pricing/compensationNAA
         
NexteraNEE65339F1015/23/2019MDirectorsYFF
NexteraNEE65339F1015/23/2019MAuditorsYFF
NexteraNEE65339F1015/23/2019MCompensationYFF
NexteraNEE65339F1015/23/2019SPolitical ContributionsYFA
         
CMS EnergyCMS1258961005/3/2019MDirectorsYFF
CMS EnergyCMS1258961005/3/2019MAuditorsYFF
CMS EnergyCMS1258961005/3/2019MCompensationYFF
CMS EnergyCMS1258961005/3/2019SPolitical ContributionsYFA
         
         
AllstateALL0200021015/21/2019MDirectorsYFF
AllstateALL0200021015/21/2019MAuditorsYFF
AllstateALL0200021015/21/2019MCompensationYFF
AllstateALL0200021015/21/2019MEquity incentive planYFF
AllstateALL0200021015/21/2019SPolitical ContributionsYFA
         
AllerganAGNG0177J1085/1/2019MDirectorsYFF
AllerganAGNG0177J1085/1/2019MCompensationYFF
AllerganAGNG0177J1085/1/2019Mcash share issuanceYFF
AllerganAGNG0177J1085/1/2019MAccountingYFF
AllerganAGNG0177J1085/1/2019MShare issuanceYFF
AllerganAGNG0177J1085/1/2019SIndependent ChairmanNAA
         
Bausch HealthBHC0717341074/30/2019MDirectorsYFF
Bausch HealthBHC0717341074/30/2019MCompensationYFF
Bausch HealthBHC0717341074/30/2019MAuditorsYFF
         
SynergySYGP8716393084/11/2019MPlanYFNone
SynergySYGP8716393084/11/2019MReleasesYFNone
         
FlotekFTK3433891025/24/2019MDirectorsYFF
FlotekFTK3433891025/24/2019MAuditorsYFF
FlotekFTK3433891025/24/2019MCompensationYFF
FlotekFTK3433891025/24/2019MDirector IncentiveYFF
FlotekFTK3433891025/24/2019MStock purchase planYFF
FlotekFTK3433891025/24/2019MLong-Term IncentiveYFF
FlotekFTK3433891025/24/2019MFrequencyY1yr.F
         
AmercoUHAL0235861008/23/2018MDirectorsYFF
AmercoUHAL0235861008/23/2018MBoard decisionsYFF
AmercoUHAL0235861008/23/2018MAccountingYFF
         
AshlandASH441861042/8/2019MDirectorsYFF
AshlandASH441861042/8/2019MAuditorsYFF
AshlandASH441861042/8/2019MCompensationYFF
         
ProthenaPRTAG728001085/21/2019MDirectorsYFF
ProthenaPRTAG728001085/21/2019MAuditorsYFF
ProthenaPRTAG728001085/21/2019MCompensationYFF
         
Supernus Pharm.SUPN8684591086/11/2019MDirectorsYFF
Supernus Pharm.SUPN8684591086/11/2019MAuditorsYFF
Supernus Pharm.SUPN8684591086/11/2019MCompensationYFF
         
AbbottABT0028241004/26/2019MDirectorsYFF
AbbottABT0028241004/26/2019MSay on PayYFF
AbbottABT0028241004/26/2019MAccountingYFF
AbbottABT0028241004/26/2019SIndependent ChairmanNAA
         
Sirius XM HoldingSIRI82968B1036/5/2019MDirectorsYFF
Sirius XM HoldingSIRI82968B1036/5/2019MAccountingYFF
         
Duke EnergyDUK26441C2045/2/2019MDirectorsYFF
Duke EnergyDUK26441C2045/2/2019MAuditorsYFF
Duke EnergyDUK26441C2045/2/2019MCompensationYFF
Duke EnergyDUK26441C2045/2/2019SPolitical contributionsYFA
Duke EnergyDUK26441C2045/2/2019SCoal useNAA
Duke EnergyDUK26441C2045/2/2019Senvironment activitiesNAA
Duke EnergyDUK26441C2045/2/2019SLobbying ExpensesYFA
         
AvistaAVA05379B1075/9/2019MDirectorsYFF
AvistaAVA05379B1075/9/2019MAuditorsYFF
AvistaAVA05379B1075/9/2019MCompensationYFF
         
SolitarioXPL8342EP1076/17/2019MDirectorsYFF
SolitarioXPL8342EP1076/17/2019MAuditorsYFF
SolitarioXPL8342EP1076/17/2019MCompensationYFF
         
XCEL EnergyXEL98389B1005/15/2019MDirectorsYFF
XCEL EnergyXEL98389B1005/15/2019MAuditorsYFF
XCEL EnergyXEL98389B1005/15/2019MCompensationYFF
         
WEC EnergyWEC9766571065/2/2019MDirectorsYFF
WEC EnergyWEC9766571065/2/2019MAuditorsYFF
WEC EnergyWEC9766571065/2/2019MCompensationYFF
         
General ElectricGE3696041035/8/2019MDirectorsYFF
General ElectricGE3696041035/8/2019MAuditorsYFF
General ElectricGE3696041035/8/2019MCompensationYFF
General ElectricGE3696041035/8/2019MDirector reductionYFF
General ElectricGE3696041035/8/2019SIndependent ChairmanNAA
General ElectricGE3696041035/8/2019SCumulative votingNAA
         
General MotorsGM37045V1006/4/2019MDirectorsYFF
General MotorsGM37045V1006/4/2019MAuditorsYFF
General MotorsGM37045V1006/4/2019MCompensationYFF
General MotorsGM37045V1006/4/2019SLobbyingYFA
General MotorsGM37045V1006/4/2019SIndependent ChairmanNAA
         
ValvolineVVV92047W1011/31/2019MDirectorsYFF
ValvolineVVV92047W1011/31/2019MAuditorsYFF
ValvolineVVV92047W1011/31/2019MCompensationYFF
ValvolineVVV92047W1011/31/2019MIncentive planYFF

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Bruce Fund, Inc.

 

By:/s/ Robert B. Bruce 
 Robert B. Bruce, President 
   
Date:8-8-2019